Lisata Therapeutics Inc (LSTA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LSTA Annual Balance Sheets →
Tracking balance sheet results across Lisata Therapeutics Inc to Jun 30 2025 helps illustrate how Jun 30 2026's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent10.44
Marketable Securities, Total MA8.83
Cash & Short-term Investments18.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.57
Total Current Assets11.01
Equipment/Property/Plant Net0.49
Intangible Assets0.40
Other Assets, Noncurrent0.00
Total Assets11.03
Liabilities
Accounts Payable, Current AC0.84
Accrued Liabilities, Current AC2.15
Other Liabilities, Current0.00
Total Current Liabilities2.99
Total Long-term Debt0.00
Other liabilities, Noncurrent0.05
Total Liabilities3.04
Stockholders' Equity
Treasury Stock Common Value-0.71
Common Stock Value0.01
Additional Paid In Capital Common Stock581.03
Retained Earnings / Accumulated Deficit-572.07
Accumulated Other Comprehensive Income-0.02
Other Equity-0.02
Common Stockholder's Equity8.50
Non-controlling interests & other-0.25
Total Stockholder's Equity8.24
Liabilities & Stockholder's Equity11.03
4 historic quarters locked

Sign in to unlock the full Lisata Therapeutics Inc balance sheet history.

About Lisata Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000320017-26-000038

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.